A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. Issue 4 (December 2015) - Bachert, Claus; Fokkens, Wytske; Hellings, Peter; Scadding, Glenis; Munzel, Ullrich; Mullol, Joaquim